Tenidap sodium does not alter the clearance or plasma protein binding of tolbutamide in healthy male volunteers.

This publication has 12 references indexed in Scilit:

• The effect of tenidap sodium on the disposition and plasma protein binding of phenytoin in healthy male volunteers.
  British Journal of Clinical Pharmacology, 1995
• MEASUREMENT OF HUMAN PHOSPHOLIPASE A IN ARTHRITIS PLASMA USING A NEWLY DEVELOPED SANDWICH ELISA
  Rheumatology, 1992
• EFFECT OF SERTRALINE ON THE PHARMACOKINETICS OF ORAL HYPOGLYCEMIC AGENTS IN HEALTHY VOLUNTEERS
  Clinical Neuropharmacology, 1992
• Drug liberations With Non Steroidal Anti-Inflammatory Drugs (NSAIDs)
  Scandinavian Journal of Rheumatology, 1989
• CP-66,248, a new anti-inflammatory agent, is a potent inhibitor of leukotriene B4 and prostanoid synthesis in human polymorphonuclear leucocytes in vitro.
  1988
• Cotrimoxazole as an inhibitor of oxidative drug metabolism: effects of trimethoprim and sulphamethoxazole separately and combined on tolbutamide disposition.
  British Journal of Clinical Pharmacology, 1985
• Effects of total plasma concentration and age on tolbutamide plasma protein binding
  Clinical Pharmacology & Therapeutics, 1982
• The effect of sulphinpyrazone on oxidative drug metabolism in man: Inhibition of tolbutamide elimination
  European Journal of Clinical Pharmacology, 1982
• Simple, rapid and micro high-pressure liquid chromatographic method for the simultaneous determination of tolbutamide and carboxy tolbutamide in plasma
  Journal of Chromatography B: Biomedical Sciences and Applications, 1978
• Binding of Sulfonylureas to Serum Proteins
  Journal of Pharmaceutical Sciences, 1972